(Image: Pixabay/Allinonemovie)

T cell cytokine ‘backpacks’ target solid tumours

By Ben Hargreaves

Researchers from MIT have devised a way for T cells to be engineered to carry nanoparticle ‘backpacks’ that can deliver the payload only when interacting with the target tumour cells.


Sanofi expands R&D in China with €66m Chengdu Hub

By Flora Southey

Sanofi will support development of polypeptides, gene therapy, monoclonal antibodies and multi-specific antibodies through the expansion of its R&D plant in Chengdu, Sichuan province, China.

(Image: Getty/CIPhotos)

Shire sells cancer biz for $2.4bn

By Flora Southey

Shire has sold its oncology business to French firm Servier S.A.S as it looks to better align its long-term strategy.


“We need Big Pharma and we are getting Big Pharma,” says Dyadic

Dyadic confident Big Biopharma will move away from CHO cell reliance

By Dan Stanton

Dyadic International says a string of deals shows biopharma is beginning to embrace its low-cost and high-yielding – yet commercially unproven – fungus-based expression platform.